Rapporto sull’analisi delle dimensioni del mercato del trattamento delle infezioni del tratto respiratorio e dell’analisi delle quote | Previsioni 2031

  • Report Code : TIPRE00003835
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

Si prevede che la dimensione del mercato del trattamento delle infezioni delle vie respiratorie raggiungerà i 69,13 miliardi di dollari entro il 2031 rispetto ai 43,6 miliardi di dollari del 2023; si prevede che registrerà un CAGR del 5,93% nel periodo 2023-2031.

Le infezioni del tratto respiratorio, o RTI, sono infezioni di i seni, la gola, le vie aeree o i polmoni. Il rapporto sul mercato globale del trattamento delle infezioni del tratto respiratorio sottolinea i fattori chiave che guidano il mercato e descrive gli sviluppi di importanti attori. I fattori chiave che guidano la crescita del mercato includono la crescente prevalenza di infezioni respiratorie a livello globale, una maggiore consapevolezza relativa alle infezioni delle vie respiratorie e varie terapie correlate alle infezioni delle vie respiratorie e un numero crescente di studi clinici relativi al trattamento delle infezioni delle vie respiratorie . Tuttavia, la mancanza di ricerca focalizzata sulle terapie respiratorie e sugli effetti avversi legati ai farmaci per le infezioni respiratorie ostacola la crescita del mercato. Inoltre, si prevede che l'avvento del trattamento antivirale porterà nuove tendenze di mercato globali per il trattamento delle infezioni del tratto respiratorio nei prossimi anni.

Fattori e limiti della crescita:

Crescente domanda di diagnosi di malattie respiratorie tra la popolazione anzianaPaesaggio competitivo e aziende chiave:

Il sistema respiratorio globale Le previsioni del mercato del trattamento delle infezioni del tratto urinario possono aiutare le parti interessate a pianificare le proprie strategie di crescita. Abbott Laboratories, AstraZeneca plc, Alembic Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche AG, Sanofi SA, Merck & Co., Cipla sono tra i principali attori profilati nel rapporto sul mercato globale del trattamento delle infezioni del tratto respiratorio. Queste aziende si concentrano su varie strategie (incluse quelle organiche e inorganiche) per soddisfare la crescente domanda dei consumatori ed espandere la propria gamma di prodotti in portafogli specializzati. Le principali strategie adottate dalle aziende sul mercato includono il lancio di nuove tecnologie, lo sviluppo di prodotti esistenti e l'espansione geografica.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which drug segment dominates the respiratory tract infection treatment market?

Based on drug, the market is segmented into Antibiotics, NSAIDs, Cough Suppressants, Nasal Decongestants, and Others. The antibiotics segment held the largest respiratory tract infection treatment market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.

Which disease indication segment dominates the respiratory tract infection treatment market?

Based on disease indication, the respiratory tract infection treatment market is segmented into LRTI and URTI. The LRTI is anticipated to hold a significant share by 2031.

What was the estimated respiratory tract infection treatment market size in 2023?

The respiratory tract infection treatment market was valued at US$ 43.60 billion in 2023.

What are the growth estimates for the respiratory tract infection treatment market till 2031?

The respiratory tract infection treatment market is expected to be valued at US$ 69.13 billion in 2031.

Who are the major players in the respiratory tract infection treatment market?

The respiratory tract infection treatment market has major market players, including Abbott Laboratories, AstraZeneca plc, Alembic Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche AG, Sanofi S.A., Merck & Co and Cipla.

What factors drive the respiratory tract infection treatment market?

The key factors driving the respiratory tract infection treatment market growth are the demand for the diagnosis of respiratory diseases owing to the rising prevalence of these diseases coupled with rising demand for OTC products. In addition, continuous research and development in this field has resulted in various diagnostic tests and procedures that will positively affect the growth of the market in the coming years.

What is respiratory tract infection treatment?

Respiratory diseases such as asthma, bronchitis, allergic rhinitis, pneumonia and sinusitis can seriously impair a person's physical functioning. Symptoms associated with both mild and severe diseases of these respiratory tracts include cough, wheezing, chest pain, difficulty breathing, and shortness of breath, congestion and, in severe cases, even death. These conditions cause significant morbidity and high costs to society. Treatment of the above respiratory disease is known as respiratory tract infection treatment.

The List of Companies - Respiratory Tract Infection Market

  1. Merck & Co
  2. Abbott
  3. AbbVie
  4. Sanofi
  5. GlaxoSmithKline plc
  6. F. Hoffmann La Roche Ltd.
  7. Pfizer, Inc.
  8. Novartis AG
  9. Teva Pharmaceuticals
  10. Boehringer Ingelheim GmbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports